Endoscopic Sinus Surgery (ESS): Risks, Benefits, and What to Expect

Endoscopic Sinus Surgery (ESS) is a minimally invasive, intranasal procedure to treat chronic rhinosinusitis (CRS), nasal polyps, sinus tumors, and other sinonasal conditions. Using rigid endoscopes and micro-instruments, surgeons open natural sinus drainage pathways (ostia) and remove obstructive tissue—preserving mucosa and anatomy.

Common Indications

  • Chronic rhinosinusitis refractory to maximal medical therapy (≥12 weeks antibiotics, intranasal steroids, saline irrigation)
  • Nasal polyposis (often with asthma, aspirin-exacerbated respiratory disease)
  • Recurrent acute sinusitis (≥4 episodes/year)
  • Sinus mucocele, fungal sinusitis, selected tumors
  • CSF leak repair, orbital decompression, optic nerve decompression

Key Risks & Complications

  1. Bleeding: Intraoperative (usually controlled) or delayed (post-op day 1–10). Significant hemorrhage <1%; may require packing, transfusion, or return to OR.
  2. Infection: Sinusitis, cellulitis, rare orbital/intracranial extension. Prophylactic antibiotics often given.
  3. Cerebrospinal Fluid (CSF) Leak: <1% (higher with skull base surgery). May require lumbar drain or endoscopic repair.
  4. Orbital Injury: Medial wall (lamina papyracea) violation → orbital hematoma, emphysema, extraocular muscle injury, vision loss (rare).
  5. Skull Base / Intracranial Injury: Cribriform plate, fovea ethmoidalis – CSF leak, meningitis, encephalitis.
  6. Adhesions / Synechiae: Scarring between septum/turbinates and lateral wall → recurrent obstruction. Mitigated by spacers, stents, postoperative debridement.
  7. Anosmia / Hyposmia: Temporary (edema) or permanent (olfactory filament injury). Risk ~1–5%.
  8. Nasolacrimal Duct Injury: Epiphora (tearing); may require stenting or DCR.
  9. Recurrence / Revision Surgery: 10–20% at 5 years for CRSwNP; lower for CRSsNP. Depends on disease biology, compliance, allergy control.

What to Expect

  • Anesthesia: General (most common) or monitored anesthesia care.
  • Duration: 1–3 hours depending on extent.
  • Packing: Dissolvable (most common) or removable (1–3 days).
  • Recovery: Same-day discharge typical. Nasal congestion, drainage, fatigue 1–2 weeks.
  • Post-op Care: Saline irrigations (start day 1), topical steroids, debridement visits (weekly × 3–6), activity restrictions (no blowing nose, heavy lifting, straining × 2 weeks).
  • Outcomes: 80–90% symptom improvement in CRS; QOL gains sustained with maintenance therapy.

Shared Decision-Making

Discuss specific risks for your anatomy, disease severity, surgeon experience, and goals. ESS is highly effective for appropriate candidates but not a cure for all sinonasal pathology.

Gonorrhea - Related Articles